nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0717	0.151	CbGbCtD
Fluticasone Propionate—CYP3A7—Estradiol—osteoporosis	0.0717	0.151	CbGbCtD
Fluticasone Propionate—CYP3A5—Estradiol—osteoporosis	0.0538	0.113	CbGbCtD
Fluticasone Propionate—CYP3A4—Estropipate—osteoporosis	0.0505	0.106	CbGbCtD
Fluticasone Propionate—CYP3A4—Calcitriol—osteoporosis	0.0505	0.106	CbGbCtD
Fluticasone Propionate—CYP3A4—Ergocalciferol—osteoporosis	0.0404	0.0849	CbGbCtD
Fluticasone Propionate—CYP3A4—Raloxifene—osteoporosis	0.0337	0.0708	CbGbCtD
Fluticasone Propionate—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0325	0.0684	CbGbCtD
Fluticasone Propionate—CYP3A4—Cholecalciferol—osteoporosis	0.026	0.0547	CbGbCtD
Fluticasone Propionate—CYP3A4—Conjugated Estrogens—osteoporosis	0.0239	0.0502	CbGbCtD
Fluticasone Propionate—CYP3A4—Estradiol—osteoporosis	0.021	0.0441	CbGbCtD
Fluticasone Propionate—PLA2G4A—Estradiol—Estropipate—osteoporosis	0.0026	0.418	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Estradiol—Conjugated Estrogens—osteoporosis	0.00197	0.316	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Estradiol—Ethinyl Estradiol—osteoporosis	0.00165	0.266	CbGdCrCtD
Fluticasone Propionate—Conjunctivitis—Estradiol—osteoporosis	0.000413	0.00102	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Alendronate—osteoporosis	0.000413	0.00102	CcSEcCtD
Fluticasone Propionate—Infection—Ethinyl Estradiol—osteoporosis	0.000413	0.00102	CcSEcCtD
Fluticasone Propionate—Cough—Pamidronate—osteoporosis	0.000412	0.00102	CcSEcCtD
Fluticasone Propionate—Pain—Calcitriol—osteoporosis	0.000411	0.00102	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000407	0.00101	CcSEcCtD
Fluticasone Propionate—Hypertension—Pamidronate—osteoporosis	0.000407	0.00101	CcSEcCtD
Fluticasone Propionate—Urticaria—Estropipate—osteoporosis	0.000407	0.00101	CcSEcCtD
Fluticasone Propionate—Vision blurred—Zoledronate—osteoporosis	0.000406	0.001	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Raloxifene—osteoporosis	0.000406	0.001	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Etidronic acid—osteoporosis	0.000405	0.001	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Estropipate—osteoporosis	0.000405	0.001	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Estropipate—osteoporosis	0.000405	0.001	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Ibandronate—osteoporosis	0.000405	0.001	CcSEcCtD
Fluticasone Propionate—Tremor—Zoledronate—osteoporosis	0.000404	0.000998	CcSEcCtD
Fluticasone Propionate—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000403	0.000998	CcSEcCtD
Fluticasone Propionate—Infection—Risedronate—osteoporosis	0.000402	0.000995	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Ibandronate—osteoporosis	0.000402	0.000994	CcSEcCtD
Fluticasone Propionate—Arthralgia—Pamidronate—osteoporosis	0.000402	0.000993	CcSEcCtD
Fluticasone Propionate—Urticaria—Alendronate—osteoporosis	0.000401	0.000992	CcSEcCtD
Fluticasone Propionate—Epistaxis—Estradiol—osteoporosis	0.000401	0.000991	CcSEcCtD
Fluticasone Propionate—Anxiety—Pamidronate—osteoporosis	0.0004	0.00099	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Zoledronate—osteoporosis	0.0004	0.000989	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Alendronate—osteoporosis	0.000399	0.000987	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Alendronate—osteoporosis	0.000399	0.000987	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000399	0.000986	CcSEcCtD
Fluticasone Propionate—Sinusitis—Estradiol—osteoporosis	0.000399	0.000986	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Risedronate—osteoporosis	0.000397	0.000982	CcSEcCtD
Fluticasone Propionate—Discomfort—Pamidronate—osteoporosis	0.000397	0.000981	CcSEcCtD
Fluticasone Propionate—Agitation—Zoledronate—osteoporosis	0.000396	0.000979	CcSEcCtD
Fluticasone Propionate—Angioedema—Zoledronate—osteoporosis	0.000394	0.000974	CcSEcCtD
Fluticasone Propionate—Skin disorder—Risedronate—osteoporosis	0.000393	0.000973	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Calcitriol—osteoporosis	0.000393	0.000973	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Raloxifene—osteoporosis	0.000392	0.00097	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Raloxifene—osteoporosis	0.000392	0.00097	CcSEcCtD
Fluticasone Propionate—Vision blurred—Conjugated Estrogens—osteoporosis	0.000391	0.000967	CcSEcCtD
Fluticasone Propionate—Urticaria—Ibandronate—osteoporosis	0.00039	0.000965	CcSEcCtD
Fluticasone Propionate—Malaise—Zoledronate—osteoporosis	0.000389	0.000961	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Ibandronate—osteoporosis	0.000388	0.000961	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Ibandronate—osteoporosis	0.000388	0.000961	CcSEcCtD
Fluticasone Propionate—Oedema—Pamidronate—osteoporosis	0.000385	0.000952	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Pamidronate—osteoporosis	0.000385	0.000952	CcSEcCtD
Fluticasone Propionate—Infection—Pamidronate—osteoporosis	0.000382	0.000946	CcSEcCtD
Fluticasone Propionate—Urticaria—Calcitriol—osteoporosis	0.000382	0.000945	CcSEcCtD
Fluticasone Propionate—Palpitations—Zoledronate—osteoporosis	0.000381	0.000942	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Calcitriol—osteoporosis	0.00038	0.00094	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Calcitriol—osteoporosis	0.00038	0.00094	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Estradiol—osteoporosis	0.000379	0.000939	CcSEcCtD
Fluticasone Propionate—Angioedema—Conjugated Estrogens—osteoporosis	0.000379	0.000937	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Estradiol—osteoporosis	0.000379	0.000936	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Estropipate—osteoporosis	0.000378	0.000934	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Pamidronate—osteoporosis	0.000378	0.000934	CcSEcCtD
Fluticasone Propionate—Vomiting—Etidronic acid—osteoporosis	0.000377	0.000931	CcSEcCtD
Fluticasone Propionate—Cough—Zoledronate—osteoporosis	0.000376	0.00093	CcSEcCtD
Fluticasone Propionate—Tachycardia—Pamidronate—osteoporosis	0.000376	0.000929	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Estradiol—osteoporosis	0.000375	0.000927	CcSEcCtD
Fluticasone Propionate—Rash—Etidronic acid—osteoporosis	0.000373	0.000924	CcSEcCtD
Fluticasone Propionate—Dermatitis—Etidronic acid—osteoporosis	0.000373	0.000923	CcSEcCtD
Fluticasone Propionate—Hypertension—Zoledronate—osteoporosis	0.000372	0.00092	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Alendronate—osteoporosis	0.000372	0.00092	CcSEcCtD
Fluticasone Propionate—Headache—Etidronic acid—osteoporosis	0.000371	0.000918	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000369	0.000912	CcSEcCtD
Fluticasone Propionate—Chest pain—Zoledronate—osteoporosis	0.000367	0.000907	CcSEcCtD
Fluticasone Propionate—Arthralgia—Zoledronate—osteoporosis	0.000367	0.000907	CcSEcCtD
Fluticasone Propionate—Palpitations—Conjugated Estrogens—osteoporosis	0.000367	0.000907	CcSEcCtD
Fluticasone Propionate—Anxiety—Zoledronate—osteoporosis	0.000366	0.000904	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000364	0.000901	CcSEcCtD
Fluticasone Propionate—Pruritus—Estropipate—osteoporosis	0.000363	0.000897	CcSEcCtD
Fluticasone Propionate—Discomfort—Zoledronate—osteoporosis	0.000362	0.000896	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Ibandronate—osteoporosis	0.000362	0.000895	CcSEcCtD
Fluticasone Propionate—Cough—Conjugated Estrogens—osteoporosis	0.000362	0.000895	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Risedronate—osteoporosis	0.000361	0.000893	CcSEcCtD
Fluticasone Propionate—Dry mouth—Zoledronate—osteoporosis	0.000359	0.000887	CcSEcCtD
Fluticasone Propionate—Pruritus—Alendronate—osteoporosis	0.000357	0.000883	CcSEcCtD
Fluticasone Propionate—Eye disorder—Estradiol—osteoporosis	0.000356	0.000881	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Calcitriol—osteoporosis	0.000354	0.000876	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Estradiol—osteoporosis	0.000354	0.000875	CcSEcCtD
Fluticasone Propionate—Arthralgia—Conjugated Estrogens—osteoporosis	0.000353	0.000873	CcSEcCtD
Fluticasone Propionate—Chest pain—Conjugated Estrogens—osteoporosis	0.000353	0.000873	CcSEcCtD
Fluticasone Propionate—Anxiety—Conjugated Estrogens—osteoporosis	0.000352	0.00087	CcSEcCtD
Fluticasone Propionate—Nausea—Etidronic acid—osteoporosis	0.000352	0.00087	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Zoledronate—osteoporosis	0.000352	0.00087	CcSEcCtD
Fluticasone Propionate—Oedema—Zoledronate—osteoporosis	0.000352	0.00087	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000351	0.000867	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000351	0.000867	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Estropipate—osteoporosis	0.000351	0.000867	CcSEcCtD
Fluticasone Propionate—Infection—Zoledronate—osteoporosis	0.000349	0.000864	CcSEcCtD
Fluticasone Propionate—Pruritus—Ibandronate—osteoporosis	0.000348	0.00086	CcSEcCtD
Fluticasone Propionate—Pain—Risedronate—osteoporosis	0.000346	0.000856	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Alendronate—osteoporosis	0.000345	0.000854	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Zoledronate—osteoporosis	0.000345	0.000853	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Estradiol—osteoporosis	0.000345	0.000852	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Estradiol—osteoporosis	0.000344	0.00085	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Pamidronate—osteoporosis	0.000343	0.000849	CcSEcCtD
Fluticasone Propionate—Tachycardia—Zoledronate—osteoporosis	0.000343	0.000849	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000342	0.000846	CcSEcCtD
Fluticasone Propionate—Skin disorder—Zoledronate—osteoporosis	0.000342	0.000845	CcSEcCtD
Fluticasone Propionate—Pruritus—Calcitriol—osteoporosis	0.00034	0.000842	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00034	0.00084	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Raloxifene—osteoporosis	0.00034	0.00084	CcSEcCtD
Fluticasone Propionate—Dizziness—Estropipate—osteoporosis	0.000339	0.000838	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000339	0.000837	CcSEcCtD
Fluticasone Propionate—Oedema—Conjugated Estrogens—osteoporosis	0.000339	0.000837	CcSEcCtD
Fluticasone Propionate—Infection—Conjugated Estrogens—osteoporosis	0.000336	0.000832	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Ibandronate—osteoporosis	0.000336	0.000831	CcSEcCtD
Fluticasone Propionate—Mental disorder—Estradiol—osteoporosis	0.000334	0.000826	CcSEcCtD
Fluticasone Propionate—Dizziness—Alendronate—osteoporosis	0.000334	0.000825	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000332	0.000821	CcSEcCtD
Fluticasone Propionate—Malnutrition—Estradiol—osteoporosis	0.000332	0.000821	CcSEcCtD
Fluticasone Propionate—Erythema—Estradiol—osteoporosis	0.000332	0.000821	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Risedronate—osteoporosis	0.000331	0.000819	CcSEcCtD
Fluticasone Propionate—Tachycardia—Conjugated Estrogens—osteoporosis	0.00033	0.000817	CcSEcCtD
Fluticasone Propionate—Urticaria—Ethinyl Estradiol—osteoporosis	0.00033	0.000816	CcSEcCtD
Fluticasone Propionate—Pain—Pamidronate—osteoporosis	0.000329	0.000814	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Calcitriol—osteoporosis	0.000329	0.000814	CcSEcCtD
Fluticasone Propionate—Skin disorder—Conjugated Estrogens—osteoporosis	0.000329	0.000813	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000328	0.000812	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000328	0.000812	CcSEcCtD
Fluticasone Propionate—Dizziness—Raloxifene—osteoporosis	0.000328	0.000812	CcSEcCtD
Fluticasone Propionate—Vomiting—Estropipate—osteoporosis	0.000326	0.000806	CcSEcCtD
Fluticasone Propionate—Dizziness—Ibandronate—osteoporosis	0.000325	0.000804	CcSEcCtD
Fluticasone Propionate—Rash—Estropipate—osteoporosis	0.000323	0.000799	CcSEcCtD
Fluticasone Propionate—Dermatitis—Estropipate—osteoporosis	0.000323	0.000798	CcSEcCtD
Fluticasone Propionate—Urticaria—Risedronate—osteoporosis	0.000322	0.000796	CcSEcCtD
Fluticasone Propionate—Headache—Estropipate—osteoporosis	0.000321	0.000794	CcSEcCtD
Fluticasone Propionate—Vomiting—Alendronate—osteoporosis	0.000321	0.000794	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00032	0.000792	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Risedronate—osteoporosis	0.00032	0.000792	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Risedronate—osteoporosis	0.00032	0.000792	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Estradiol—osteoporosis	0.000319	0.000789	CcSEcCtD
Fluticasone Propionate—Rash—Alendronate—osteoporosis	0.000318	0.000787	CcSEcCtD
Fluticasone Propionate—Dermatitis—Alendronate—osteoporosis	0.000318	0.000786	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Pamidronate—osteoporosis	0.000317	0.000785	CcSEcCtD
Fluticasone Propionate—Headache—Alendronate—osteoporosis	0.000316	0.000782	CcSEcCtD
Fluticasone Propionate—Vomiting—Raloxifene—osteoporosis	0.000316	0.00078	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Pamidronate—osteoporosis	0.000315	0.000778	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Zoledronate—osteoporosis	0.000313	0.000775	CcSEcCtD
Fluticasone Propionate—Rash—Raloxifene—osteoporosis	0.000313	0.000774	CcSEcCtD
Fluticasone Propionate—Dermatitis—Raloxifene—osteoporosis	0.000313	0.000773	CcSEcCtD
Fluticasone Propionate—Vomiting—Ibandronate—osteoporosis	0.000312	0.000773	CcSEcCtD
Fluticasone Propionate—Tremor—Estradiol—osteoporosis	0.000311	0.000769	CcSEcCtD
Fluticasone Propionate—Headache—Raloxifene—osteoporosis	0.000311	0.000769	CcSEcCtD
Fluticasone Propionate—Rash—Ibandronate—osteoporosis	0.00031	0.000766	CcSEcCtD
Fluticasone Propionate—Dermatitis—Ibandronate—osteoporosis	0.00031	0.000765	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000308	0.000763	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Estradiol—osteoporosis	0.000308	0.000762	CcSEcCtD
Fluticasone Propionate—Headache—Ibandronate—osteoporosis	0.000308	0.000761	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000306	0.000757	CcSEcCtD
Fluticasone Propionate—Vomiting—Calcitriol—osteoporosis	0.000306	0.000756	CcSEcCtD
Fluticasone Propionate—Agitation—Estradiol—osteoporosis	0.000305	0.000755	CcSEcCtD
Fluticasone Propionate—Nausea—Estropipate—osteoporosis	0.000304	0.000753	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Pamidronate—osteoporosis	0.000304	0.000753	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Pamidronate—osteoporosis	0.000304	0.000753	CcSEcCtD
Fluticasone Propionate—Angioedema—Estradiol—osteoporosis	0.000303	0.00075	CcSEcCtD
Fluticasone Propionate—Rash—Calcitriol—osteoporosis	0.000303	0.00075	CcSEcCtD
Fluticasone Propionate—Dermatitis—Calcitriol—osteoporosis	0.000303	0.000749	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000302	0.000747	CcSEcCtD
Fluticasone Propionate—Headache—Calcitriol—osteoporosis	0.000301	0.000745	CcSEcCtD
Fluticasone Propionate—Pain—Zoledronate—osteoporosis	0.000301	0.000744	CcSEcCtD
Fluticasone Propionate—Nausea—Alendronate—osteoporosis	0.0003	0.000741	CcSEcCtD
Fluticasone Propionate—Malaise—Estradiol—osteoporosis	0.000299	0.00074	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Risedronate—osteoporosis	0.000298	0.000738	CcSEcCtD
Fluticasone Propionate—Nausea—Raloxifene—osteoporosis	0.000295	0.000729	CcSEcCtD
Fluticasone Propionate—Pruritus—Ethinyl Estradiol—osteoporosis	0.000294	0.000727	CcSEcCtD
Fluticasone Propionate—Palpitations—Estradiol—osteoporosis	0.000293	0.000726	CcSEcCtD
Fluticasone Propionate—Nausea—Ibandronate—osteoporosis	0.000292	0.000722	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Zoledronate—osteoporosis	0.00029	0.000717	CcSEcCtD
Fluticasone Propionate—Cough—Estradiol—osteoporosis	0.00029	0.000717	CcSEcCtD
Fluticasone Propionate—Pain—Conjugated Estrogens—osteoporosis	0.00029	0.000716	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Zoledronate—osteoporosis	0.000288	0.000711	CcSEcCtD
Fluticasone Propionate—Hypertension—Estradiol—osteoporosis	0.000287	0.000709	CcSEcCtD
Fluticasone Propionate—Pruritus—Risedronate—osteoporosis	0.000286	0.000709	CcSEcCtD
Fluticasone Propionate—Nausea—Calcitriol—osteoporosis	0.000286	0.000707	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000284	0.000703	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Pamidronate—osteoporosis	0.000284	0.000701	CcSEcCtD
Fluticasone Propionate—Chest pain—Estradiol—osteoporosis	0.000283	0.000699	CcSEcCtD
Fluticasone Propionate—Arthralgia—Estradiol—osteoporosis	0.000283	0.000699	CcSEcCtD
Fluticasone Propionate—Anxiety—Estradiol—osteoporosis	0.000282	0.000697	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000281	0.000694	CcSEcCtD
Fluticasone Propionate—Urticaria—Zoledronate—osteoporosis	0.000279	0.000691	CcSEcCtD
Fluticasone Propionate—Discomfort—Estradiol—osteoporosis	0.000279	0.000691	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Zoledronate—osteoporosis	0.000278	0.000687	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Zoledronate—osteoporosis	0.000278	0.000687	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Risedronate—osteoporosis	0.000277	0.000685	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000277	0.000685	CcSEcCtD
Fluticasone Propionate—Dry mouth—Estradiol—osteoporosis	0.000276	0.000684	CcSEcCtD
Fluticasone Propionate—Dizziness—Ethinyl Estradiol—osteoporosis	0.000275	0.000679	CcSEcCtD
Fluticasone Propionate—Pruritus—Pamidronate—osteoporosis	0.000272	0.000674	CcSEcCtD
Fluticasone Propionate—Oedema—Estradiol—osteoporosis	0.000271	0.00067	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Estradiol—osteoporosis	0.000271	0.00067	CcSEcCtD
Fluticasone Propionate—Infection—Estradiol—osteoporosis	0.000269	0.000666	CcSEcCtD
Fluticasone Propionate—Urticaria—Conjugated Estrogens—osteoporosis	0.000269	0.000665	CcSEcCtD
Fluticasone Propionate—Dizziness—Risedronate—osteoporosis	0.000268	0.000662	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000268	0.000662	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000268	0.000662	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Estradiol—osteoporosis	0.000266	0.000657	CcSEcCtD
Fluticasone Propionate—Tachycardia—Estradiol—osteoporosis	0.000264	0.000654	CcSEcCtD
Fluticasone Propionate—Vomiting—Ethinyl Estradiol—osteoporosis	0.000264	0.000653	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Pamidronate—osteoporosis	0.000263	0.000651	CcSEcCtD
Fluticasone Propionate—Skin disorder—Estradiol—osteoporosis	0.000263	0.000651	CcSEcCtD
Fluticasone Propionate—Rash—Ethinyl Estradiol—osteoporosis	0.000262	0.000648	CcSEcCtD
Fluticasone Propionate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000262	0.000647	CcSEcCtD
Fluticasone Propionate—Headache—Ethinyl Estradiol—osteoporosis	0.00026	0.000643	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Zoledronate—osteoporosis	0.000259	0.000641	CcSEcCtD
Fluticasone Propionate—Vomiting—Risedronate—osteoporosis	0.000257	0.000637	CcSEcCtD
Fluticasone Propionate—Rash—Risedronate—osteoporosis	0.000255	0.000631	CcSEcCtD
Fluticasone Propionate—Dermatitis—Risedronate—osteoporosis	0.000255	0.000631	CcSEcCtD
Fluticasone Propionate—Dizziness—Pamidronate—osteoporosis	0.000255	0.00063	CcSEcCtD
Fluticasone Propionate—Headache—Risedronate—osteoporosis	0.000254	0.000627	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000249	0.000617	CcSEcCtD
Fluticasone Propionate—Pruritus—Zoledronate—osteoporosis	0.000249	0.000615	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000247	0.000611	CcSEcCtD
Fluticasone Propionate—Nausea—Ethinyl Estradiol—osteoporosis	0.000247	0.00061	CcSEcCtD
Fluticasone Propionate—Vomiting—Pamidronate—osteoporosis	0.000245	0.000605	CcSEcCtD
Fluticasone Propionate—Rash—Pamidronate—osteoporosis	0.000243	0.0006	CcSEcCtD
Fluticasone Propionate—Dermatitis—Pamidronate—osteoporosis	0.000242	0.0006	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Estradiol—osteoporosis	0.000242	0.000597	CcSEcCtD
Fluticasone Propionate—Headache—Pamidronate—osteoporosis	0.000241	0.000596	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Zoledronate—osteoporosis	0.000241	0.000595	CcSEcCtD
Fluticasone Propionate—Nausea—Risedronate—osteoporosis	0.000241	0.000595	CcSEcCtD
Fluticasone Propionate—Pruritus—Conjugated Estrogens—osteoporosis	0.00024	0.000592	CcSEcCtD
Fluticasone Propionate—Dizziness—Zoledronate—osteoporosis	0.000233	0.000575	CcSEcCtD
Fluticasone Propionate—Pain—Estradiol—osteoporosis	0.000232	0.000573	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000232	0.000573	CcSEcCtD
Fluticasone Propionate—Nausea—Pamidronate—osteoporosis	0.000229	0.000565	CcSEcCtD
Fluticasone Propionate—Dizziness—Conjugated Estrogens—osteoporosis	0.000224	0.000554	CcSEcCtD
Fluticasone Propionate—Vomiting—Zoledronate—osteoporosis	0.000224	0.000553	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Estradiol—osteoporosis	0.000223	0.000552	CcSEcCtD
Fluticasone Propionate—Rash—Zoledronate—osteoporosis	0.000222	0.000548	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Estradiol—osteoporosis	0.000222	0.000548	CcSEcCtD
Fluticasone Propionate—Dermatitis—Zoledronate—osteoporosis	0.000222	0.000548	CcSEcCtD
Fluticasone Propionate—Headache—Zoledronate—osteoporosis	0.00022	0.000545	CcSEcCtD
Fluticasone Propionate—Vomiting—Conjugated Estrogens—osteoporosis	0.000215	0.000532	CcSEcCtD
Fluticasone Propionate—Urticaria—Estradiol—osteoporosis	0.000215	0.000532	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Estradiol—osteoporosis	0.000214	0.00053	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Estradiol—osteoporosis	0.000214	0.00053	CcSEcCtD
Fluticasone Propionate—Rash—Conjugated Estrogens—osteoporosis	0.000213	0.000528	CcSEcCtD
Fluticasone Propionate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000213	0.000527	CcSEcCtD
Fluticasone Propionate—Headache—Conjugated Estrogens—osteoporosis	0.000212	0.000525	CcSEcCtD
Fluticasone Propionate—Nausea—Zoledronate—osteoporosis	0.000209	0.000517	CcSEcCtD
Fluticasone Propionate—Nausea—Conjugated Estrogens—osteoporosis	0.000201	0.000497	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Estradiol—osteoporosis	0.0002	0.000494	CcSEcCtD
Fluticasone Propionate—Pruritus—Estradiol—osteoporosis	0.000192	0.000474	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Estradiol—osteoporosis	0.000185	0.000459	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000184	0.00162	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—ESR1—osteoporosis	0.000183	0.00161	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Estradiol—osteoporosis	0.000179	0.000443	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Hemostasis—FGA—osteoporosis	0.000177	0.00156	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SOST—osteoporosis	0.000173	0.00153	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MGLL—osteoporosis	0.000172	0.00152	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Estradiol—osteoporosis	0.000172	0.000426	CcSEcCtD
Fluticasone Propionate—PGR—Gene Expression—RPL24—osteoporosis	0.000172	0.00151	CbGpPWpGaD
Fluticasone Propionate—Rash—Estradiol—osteoporosis	0.000171	0.000423	CcSEcCtD
Fluticasone Propionate—Dermatitis—Estradiol—osteoporosis	0.000171	0.000422	CcSEcCtD
Fluticasone Propionate—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.00017	0.0015	CbGpPWpGaD
Fluticasone Propionate—Headache—Estradiol—osteoporosis	0.00017	0.00042	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism—PKM—osteoporosis	0.000169	0.00149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—FDPS—osteoporosis	0.000169	0.00149	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—IRS1—osteoporosis	0.000165	0.00145	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—PSMA5—osteoporosis	0.000163	0.00143	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—PSMA2—osteoporosis	0.000163	0.00143	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000163	0.00143	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—FGB—osteoporosis	0.000161	0.00142	CbGpPWpGaD
Fluticasone Propionate—Nausea—Estradiol—osteoporosis	0.000161	0.000398	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism—GPD2—osteoporosis	0.000161	0.00141	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PGLS—osteoporosis	0.000161	0.00141	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00016	0.00141	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000159	0.0014	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTH1R—osteoporosis	0.000157	0.00138	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CALCR—osteoporosis	0.000157	0.00138	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	0.000154	0.00135	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—IGF1—osteoporosis	0.000153	0.00135	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	0.000151	0.00133	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	0.000151	0.00132	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	0.00015	0.00132	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	0.000149	0.00131	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ATIC—osteoporosis	0.000147	0.00129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PNP—osteoporosis	0.000147	0.00129	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—VDR—osteoporosis	0.000146	0.00129	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—ESR2—osteoporosis	0.000146	0.00128	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SOST—osteoporosis	0.000142	0.00125	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000141	0.00124	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	0.000134	0.00118	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000134	0.00118	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—MYC—osteoporosis	0.000134	0.00118	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—U2AF1—osteoporosis	0.000134	0.00118	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000133	0.00117	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000132	0.00116	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000131	0.00116	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CALCR—osteoporosis	0.000128	0.00113	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTH1R—osteoporosis	0.000128	0.00113	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—POMC—osteoporosis	0.000125	0.0011	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—OXCT1—osteoporosis	0.000125	0.0011	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CA2—osteoporosis	0.000125	0.0011	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MGLL—osteoporosis	0.000125	0.0011	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MGLL—osteoporosis	0.000122	0.00107	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LRP5—osteoporosis	0.000122	0.00107	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PKM—osteoporosis	0.000118	0.00104	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—FDPS—osteoporosis	0.000118	0.00104	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LRP6—osteoporosis	0.000116	0.00102	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—VDR—osteoporosis	0.000115	0.00102	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000115	0.00101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PTH—osteoporosis	0.000114	0.001	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	0.000113	0.000997	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PGLS—osteoporosis	0.000112	0.000985	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GPD2—osteoporosis	0.000112	0.000985	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—ESR1—osteoporosis	0.000112	0.000982	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CNR2—osteoporosis	0.000111	0.000977	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	0.000106	0.000936	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—IL6—osteoporosis	0.000105	0.000928	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—WNT1—osteoporosis	0.000104	0.000918	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—IDH2—osteoporosis	0.000104	0.000911	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PNP—osteoporosis	0.000102	0.000901	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ATIC—osteoporosis	0.000102	0.000901	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000102	0.000897	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MGLL—osteoporosis	0.000102	0.000895	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	9.99e-05	0.000879	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—RPL24—osteoporosis	9.93e-05	0.000874	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LRP5—osteoporosis	9.93e-05	0.000874	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PSMA5—osteoporosis	9.92e-05	0.000873	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PSMA2—osteoporosis	9.92e-05	0.000873	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TLN1—osteoporosis	9.82e-05	0.000864	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.77e-05	0.000859	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP27A1—osteoporosis	9.73e-05	0.000856	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.55e-05	0.00084	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—MYC—osteoporosis	9.53e-05	0.000839	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.53e-05	0.000838	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LRP6—osteoporosis	9.5e-05	0.000836	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ACP5—osteoporosis	9.47e-05	0.000833	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PTHLH—osteoporosis	9.44e-05	0.000831	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.35e-05	0.000822	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TGFB1—osteoporosis	9.17e-05	0.000807	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—POMC—osteoporosis	9.05e-05	0.000796	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.9e-05	0.000783	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—ESR2—osteoporosis	8.86e-05	0.00078	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—ESR1—osteoporosis	8.83e-05	0.000776	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—TPI1—osteoporosis	8.8e-05	0.000774	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—OXCT1—osteoporosis	8.7e-05	0.000766	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CA2—osteoporosis	8.7e-05	0.000766	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TNF—osteoporosis	8.56e-05	0.000753	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—FDPS—osteoporosis	8.53e-05	0.000751	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PKM—osteoporosis	8.53e-05	0.000751	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MGLL—osteoporosis	8.48e-05	0.000746	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	8.48e-05	0.000746	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—P4HB—osteoporosis	8.47e-05	0.000745	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	8.44e-05	0.000743	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CALCA—osteoporosis	8.31e-05	0.000731	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—P4HB—osteoporosis	8.27e-05	0.000728	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTH—osteoporosis	8.24e-05	0.000725	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GAPDH—osteoporosis	8.12e-05	0.000714	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RAP1A—osteoporosis	8.1e-05	0.000712	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PGLS—osteoporosis	8.09e-05	0.000712	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GPD2—osteoporosis	8.09e-05	0.000712	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CNR2—osteoporosis	8.03e-05	0.000706	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TLN1—osteoporosis	8.02e-05	0.000706	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.92e-05	0.000697	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—RAP1A—osteoporosis	7.91e-05	0.000696	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NFATC1—osteoporosis	7.9e-05	0.000695	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—DKK1—osteoporosis	7.84e-05	0.000689	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—WNT1—osteoporosis	7.55e-05	0.000664	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	7.4e-05	0.000651	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ATIC—osteoporosis	7.4e-05	0.000651	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PNP—osteoporosis	7.4e-05	0.000651	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGA—osteoporosis	7.34e-05	0.000646	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IGF1—osteoporosis	7.29e-05	0.000641	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—IDH2—osteoporosis	7.21e-05	0.000635	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—VDR—osteoporosis	7.03e-05	0.000619	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	7e-05	0.000616	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—P4HB—osteoporosis	6.92e-05	0.000609	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—IL6—osteoporosis	6.91e-05	0.000608	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	6.9e-05	0.000607	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.9e-05	0.000607	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTHLH—osteoporosis	6.83e-05	0.000601	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BMP2—osteoporosis	6.83e-05	0.000601	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP27A1—osteoporosis	6.78e-05	0.000597	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTH—osteoporosis	6.73e-05	0.000592	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGB—osteoporosis	6.68e-05	0.000588	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RAP1A—osteoporosis	6.61e-05	0.000582	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ACP5—osteoporosis	6.6e-05	0.00058	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CNR2—osteoporosis	6.56e-05	0.000577	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	6.45e-05	0.000568	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NFATC1—osteoporosis	6.45e-05	0.000568	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PSMA5—osteoporosis	6.45e-05	0.000567	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PSMA2—osteoporosis	6.45e-05	0.000567	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—DKK1—osteoporosis	6.4e-05	0.000563	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ENO1—osteoporosis	6.39e-05	0.000563	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PSMA2—osteoporosis	6.3e-05	0.000554	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PSMA5—osteoporosis	6.3e-05	0.000554	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—OXCT1—osteoporosis	6.29e-05	0.000554	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CA2—osteoporosis	6.29e-05	0.000554	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—WNT1—osteoporosis	6.17e-05	0.000542	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TPI1—osteoporosis	6.13e-05	0.00054	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MGLL—osteoporosis	6.13e-05	0.000539	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CALCA—osteoporosis	6.01e-05	0.000529	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGA—osteoporosis	6e-05	0.000528	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	5.97e-05	0.000525	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—ADCY5—osteoporosis	5.91e-05	0.00052	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MYC—osteoporosis	5.81e-05	0.000511	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—P4HB—osteoporosis	5.77e-05	0.000507	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PSMA5—osteoporosis	5.73e-05	0.000504	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PSMA2—osteoporosis	5.73e-05	0.000504	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GAPDH—osteoporosis	5.66e-05	0.000498	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTHLH—osteoporosis	5.58e-05	0.000491	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BMP2—osteoporosis	5.58e-05	0.000491	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—RAP1A—osteoporosis	5.51e-05	0.000485	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGB—osteoporosis	5.46e-05	0.00048	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KL—osteoporosis	5.46e-05	0.00048	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—ESR1—osteoporosis	5.37e-05	0.000473	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PSMA5—osteoporosis	5.27e-05	0.000463	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PSMA2—osteoporosis	5.27e-05	0.000463	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—IDH2—osteoporosis	5.21e-05	0.000459	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR2—osteoporosis	5.12e-05	0.000451	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP19A1—osteoporosis	5.11e-05	0.00045	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CALCA—osteoporosis	4.91e-05	0.000432	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP27A1—osteoporosis	4.9e-05	0.000431	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ACP5—osteoporosis	4.77e-05	0.00042	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—osteoporosis	4.59e-05	0.000404	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KL—osteoporosis	4.46e-05	0.000392	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ENO1—osteoporosis	4.46e-05	0.000392	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TPI1—osteoporosis	4.43e-05	0.00039	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PSMA2—osteoporosis	4.39e-05	0.000386	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PSMA5—osteoporosis	4.39e-05	0.000386	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB1—osteoporosis	4.37e-05	0.000384	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—POMC—osteoporosis	4.35e-05	0.000383	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ADCY5—osteoporosis	4.28e-05	0.000376	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6R—osteoporosis	4.24e-05	0.000373	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—POMC—osteoporosis	4.21e-05	0.00037	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ADCY5—osteoporosis	4.18e-05	0.000367	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—P4HB—osteoporosis	4.17e-05	0.000367	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GPX1—osteoporosis	4.16e-05	0.000366	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SPP1—osteoporosis	4.14e-05	0.000364	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GAPDH—osteoporosis	4.09e-05	0.00036	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—VDR—osteoporosis	4.07e-05	0.000358	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—RAP1A—osteoporosis	3.98e-05	0.000351	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PKM—osteoporosis	3.97e-05	0.000349	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—FDPS—osteoporosis	3.97e-05	0.000349	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MTHFR—osteoporosis	3.84e-05	0.000338	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPD2—osteoporosis	3.76e-05	0.000331	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PGLS—osteoporosis	3.76e-05	0.000331	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IRS2—osteoporosis	3.74e-05	0.000329	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LEP—osteoporosis	3.66e-05	0.000322	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP19A1—osteoporosis	3.56e-05	0.000313	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ESR1—osteoporosis	3.49e-05	0.000307	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ADCY5—osteoporosis	3.49e-05	0.000307	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ATIC—osteoporosis	3.44e-05	0.000303	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PNP—osteoporosis	3.44e-05	0.000303	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SPP1—osteoporosis	3.38e-05	0.000297	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	3.36e-05	0.000295	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IRS1—osteoporosis	3.27e-05	0.000287	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ENO1—osteoporosis	3.22e-05	0.000283	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PSMA2—osteoporosis	3.17e-05	0.000279	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PSMA5—osteoporosis	3.17e-05	0.000279	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—POMC—osteoporosis	3.14e-05	0.000277	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR1—osteoporosis	3.11e-05	0.000273	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—POMC—osteoporosis	3.07e-05	0.00027	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6R—osteoporosis	3.07e-05	0.00027	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IRS2—osteoporosis	3.06e-05	0.000269	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1—osteoporosis	3.02e-05	0.000266	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LEP—osteoporosis	2.99e-05	0.000263	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA2—osteoporosis	2.93e-05	0.000257	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—OXCT1—osteoporosis	2.93e-05	0.000257	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ADCY5—osteoporosis	2.91e-05	0.000256	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GPX1—osteoporosis	2.9e-05	0.000255	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ESR1—osteoporosis	2.85e-05	0.000251	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MGLL—osteoporosis	2.85e-05	0.000251	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—osteoporosis	2.8e-05	0.000246	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—osteoporosis	2.68e-05	0.000235	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IRS1—osteoporosis	2.67e-05	0.000235	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP19A1—osteoporosis	2.58e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—POMC—osteoporosis	2.57e-05	0.000226	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6R—osteoporosis	2.51e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1—osteoporosis	2.47e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—IDH2—osteoporosis	2.42e-05	0.000213	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.28e-05	0.0002	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ACP5—osteoporosis	2.22e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—POMC—osteoporosis	2.14e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ADCY5—osteoporosis	2.1e-05	0.000185	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GPX1—osteoporosis	2.1e-05	0.000184	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TPI1—osteoporosis	2.06e-05	0.000181	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—P4HB—osteoporosis	1.94e-05	0.00017	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—osteoporosis	1.94e-05	0.00017	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GAPDH—osteoporosis	1.9e-05	0.000167	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—osteoporosis	1.89e-05	0.000166	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—RAP1A—osteoporosis	1.85e-05	0.000163	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—osteoporosis	1.82e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—osteoporosis	1.81e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—osteoporosis	1.62e-05	0.000142	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—POMC—osteoporosis	1.55e-05	0.000136	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ENO1—osteoporosis	1.5e-05	0.000132	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—osteoporosis	1.48e-05	0.000131	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—osteoporosis	1.48e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PSMA2—osteoporosis	1.48e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PSMA5—osteoporosis	1.48e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—osteoporosis	1.37e-05	0.00012	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.2e-05	0.000105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—osteoporosis	1.12e-05	9.82e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ADCY5—osteoporosis	9.78e-06	8.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPX1—osteoporosis	9.75e-06	8.58e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—osteoporosis	9e-06	7.91e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—POMC—osteoporosis	7.19e-06	6.33e-05	CbGpPWpGaD
